Bumper Offer - Urjas oil Just @ Rs. 1
Dixin 0.25 Injection, a prescription drug, is manufactured in various forms such as Injection. It is typically used for the treatment of Heart Failure, Arrhythmia. The alternative uses of Dixin 0.25 Injection have also been explained below.
The right dosage of Dixin 0.25 Injection depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Dixin 0.25 Injection as well, which are listed below. Normally, these side effects of Dixin 0.25 Injection are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Dixin 0.25 Injection's effect during pregnancy is Severe and Safe while nursing. Warnings related to Dixin 0.25 Injection's effects on the liver, heart and kidney, if any, have been listed below.
Dixin 0.25 Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bradycardia (Slow Heart Rate), Hypercalcemia are examples of such conditions. Other contraindications of Dixin 0.25 Injection have been discussed in the sections ahead.
Drug interactions for Dixin 0.25 Injection have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Dixin 0.25 Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Dixin 0.25 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Neonates (0 to 1 month) |
|
| Infant (1 month to 2 years) |
|
Based on research, the following side effects have been observed when Dixin 0.25 Injection is used -
Severe
Mild
Is the use of Dixin 0.25 Injection safe for pregnant women?
Pregnant women may get severe side effects after taking Dixin. If you are pregnant, do not take Dixin without a doctor's advice.
Is the use of Dixin 0.25 Injection safe during breastfeeding?
Dixin is safe for breastfeeding women.
What is the effect of Dixin 0.25 Injection on the Kidneys?
Dixin may have mild side effects on the kidneys.
What is the effect of Dixin 0.25 Injection on the Liver?
Side effects of Dixin on the liver are unknown because research on this has not been conducted yet.
What is the effect of Dixin 0.25 Injection on the Heart?
Dixin is rarely harmful for the heart.
Dixin 0.25 Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Dixin 0.25 Injection unless your doctor advises you to do so -
Is this Dixin 0.25 Injection habit forming or addictive?
No, there is no any evidence that Dixin 0.25 Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Dixin 0.25 Injection. So it is best to avoid driving.
Is it safe?
Yes, but take Dixin 0.25 Injection only as per medical advice.
Is it able to treat mental disorders?
Dixin 0.25 Injection is unable to treat or cure mental disorders.
Interaction between Food and Dixin 0.25 Injection
Taking Dixin 0.25 Injection with food is safe.
Interaction between Alcohol and Dixin 0.25 Injection
It is difficult to say anything about the effect of Dixin 0.25 Injection and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 430-433
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 512-519
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lanoxin® (digoxin)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Sigmaxin (digoxin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 430-433
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 512-519
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lanoxin® (digoxin)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Sigmaxin (digoxin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 430-433
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 512-519
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lanoxin® (digoxin)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Sigmaxin (digoxin)
